Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.

NCT01949220 is registered in ClinicalTrials.gov with Laboratoire français de Fractionnement et de Biotechnologies as lead sponsor.

NCT NCT01949220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
Lead sponsor
Laboratoire français de Fractionnement et de Biotechnologies
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
December 31, 2017
Enrollment
80 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

von willebrand disease